Limba
|
ACT001(DMAMCL, dimethylaminomicheliolide) is a PAI-1inhibitor and exerts antitumor effects on neuroblastoma (NB) both in vitro and in vivo. It also exerts synergistic effects in combination with cisplatin through the inhibition of the PAI-1/PI3K/AKT pathway.
Price | 3.005,00 RON (preturile sunt fara TVA) |
---|---|
Description |
ACT001(DMAMCL, dimethylaminomicheliolide) is a PAI-1inhibitor and exerts antitumor effects on neuroblastoma (NB) both in vitro and in vivo. It also exerts synergistic effects in combination with cisplatin through the inhibition of the PAI-1/PI3K/AKT pathway. |